Financials data is unavailable for this security.
Cash flow in SEKView more
In 2023, cash reserves at Guard Therapeutics International AB (publ) fell by 117.27m. However, Cash Flow from Investing was flat, indicating that little new money was committed to growth. In addition the company used 116.05m for operations while cash used for financing totalled 779.00k.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 6.45 |
---|---|
Tangible book value per share | 6.45 |
More ▼
Balance sheet in SEKView more
Current ratio | 5.28 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼